DE60239491D1 - Thiazolidindionderivate und diese enthaltende pharmazeutische zusammensetzung - Google Patents

Thiazolidindionderivate und diese enthaltende pharmazeutische zusammensetzung

Info

Publication number
DE60239491D1
DE60239491D1 DE60239491T DE60239491T DE60239491D1 DE 60239491 D1 DE60239491 D1 DE 60239491D1 DE 60239491 T DE60239491 T DE 60239491T DE 60239491 T DE60239491 T DE 60239491T DE 60239491 D1 DE60239491 D1 DE 60239491D1
Authority
DE
Germany
Prior art keywords
pharmaceutical composition
thiazolidinde
derivatives
composition containing
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60239491T
Other languages
English (en)
Inventor
Chungil Hong
Soon-Kil Ahn
Bok-Young Kim
Joong-Bok Ahn
Do-Young Lee
Hong-Woo Lee
Jae-Soo Shin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chong Kun Dang Corp
Original Assignee
Chong Kun Dang Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chong Kun Dang Corp filed Critical Chong Kun Dang Corp
Application granted granted Critical
Publication of DE60239491D1 publication Critical patent/DE60239491D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DE60239491T 2002-03-22 2002-03-28 Thiazolidindionderivate und diese enthaltende pharmazeutische zusammensetzung Expired - Lifetime DE60239491D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2002-0015755A KR100450700B1 (ko) 2002-03-22 2002-03-22 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물
PCT/KR2002/000542 WO2003080605A1 (en) 2002-03-22 2002-03-28 Thiazolidinedione derivatives and pharmaceutical composition comprising the same

Publications (1)

Publication Number Publication Date
DE60239491D1 true DE60239491D1 (de) 2011-04-28

Family

ID=28450054

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60239491T Expired - Lifetime DE60239491D1 (de) 2002-03-22 2002-03-28 Thiazolidindionderivate und diese enthaltende pharmazeutische zusammensetzung

Country Status (11)

Country Link
US (1) US6787551B2 (de)
EP (1) EP1490360B1 (de)
JP (1) JP4181050B2 (de)
KR (1) KR100450700B1 (de)
CN (1) CN1276920C (de)
AT (1) ATE502034T1 (de)
AU (1) AU2002244985A1 (de)
CA (1) CA2479274C (de)
DE (1) DE60239491D1 (de)
ES (1) ES2360381T3 (de)
WO (1) WO2003080605A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
US20150004144A1 (en) 2011-12-02 2015-01-01 The General Hospital Corporation Differentiation into brown adipocytes
KR101721831B1 (ko) 2014-11-06 2017-03-31 주식회사 종근당 로베글리타존을 함유하는 경구 투여용 약제학적 조성물
WO2016153949A1 (en) * 2015-03-20 2016-09-29 Deuterx, Llc 5-deutero-thiazolidine-2,4-dione compounds and methods of treating medical disorders using same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物,其制备方法和用途
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
ATE186724T1 (de) 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
US5441971A (en) * 1991-04-11 1995-08-15 The Upjohn Company Thiazolidinedione derivatives, production and use thereof
CA2118706A1 (en) * 1992-07-13 1994-01-20 Saizo Shibata Novel thiazolidinedione compounds and use thereof
US6046222A (en) * 1993-09-15 2000-04-04 Warner-Lambert Company Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus
US5457109A (en) * 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
US5708012A (en) * 1995-04-28 1998-01-13 Sankyo Company, Limited Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of insulin resistant subjects with normal glucose tolerance in order to prevent or delay the onset of noninsulin-dependent mellitus
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9909075D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
TR200200438T2 (tr) * 1999-08-17 2002-05-21 Smithkline Beecham P.L.C. Tiazolidindion türevleri içeren farmasötik terkipler ve bu terkipleri hazırlama prosesi.
ES2156574B1 (es) * 1999-11-18 2002-02-01 Vita Invest Sa Nuevos derivados de tiazolidindiona como agentes antidiabeticos

Also Published As

Publication number Publication date
KR100450700B1 (ko) 2004-10-01
KR20030076094A (ko) 2003-09-26
JP2005520862A (ja) 2005-07-14
WO2003080605A1 (en) 2003-10-02
CA2479274C (en) 2010-02-16
CN1622945A (zh) 2005-06-01
ATE502034T1 (de) 2011-04-15
AU2002244985A1 (en) 2003-10-08
EP1490360B1 (de) 2011-03-16
JP4181050B2 (ja) 2008-11-12
CN1276920C (zh) 2006-09-27
US6787551B2 (en) 2004-09-07
EP1490360A4 (de) 2006-07-05
EP1490360A1 (de) 2004-12-29
ES2360381T3 (es) 2011-06-03
US20040122031A1 (en) 2004-06-24
CA2479274A1 (en) 2003-10-02

Similar Documents

Publication Publication Date Title
ATE388958T1 (de) 4'-c-substituierte 2-haloadenosinderivate
EP1775289A4 (de) Neue imidazolidinderivate
EE200200603A (et) Dipeptidüüli peptidaasi IV inhibiitorid
ATE368655T1 (de) Stickstoffhaltige heterocyclische verbindung und arzneimittel davon
JO2354B1 (en) New derivatives of aromatic fluoroglycosides and drugs containing these compounds and their use
TW200510441A (en) Novel compounds
NZ536734A (en) Spiroindolinepiperidine derivatives
HK1155146A1 (zh) 作為藥物活性劑的茚衍生物
MX2007000505A (es) Derivados de oxindol sustituidos y medicamentos que contienen los mismos.
HUP0302337A2 (hu) Pirimidin-2,4,6-trion metalloproteáz inhibitorok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
DE60129210D1 (de) Zyklische amid-derivate
DK0976748T3 (da) Pyrrolidinderivater med phospholispase A2-hæmmende aktivitet
TW200505834A (en) Sulfamide derivative and the pharmaceutical composition thereof
DE60044342D1 (de) Aminderivate
IL169184A0 (en) Aromatic compounds as anti-inflammatory, immunomdulatory and anti-proliferatory agents
HUP0000729A2 (hu) Új amidszármazékok és ezeket tartalmazó gyógyszerkészítmények
TW200626130A (en) 5-membered heterocycle derivatives
DE60239491D1 (de) Thiazolidindionderivate und diese enthaltende pharmazeutische zusammensetzung
IS6452A (is) Ný tetrahýdrópýridín, framleiðsluaðferð og lyfjasamsetningar sem innihalda þau
MXPA01013148A (es) Nuevos derivados de amonio cuaternario, metodo para la preparacion de los mismos y uso farmaceutico.
HUP0301553A2 (hu) Gyógyászati készítmények és alkalmazásuk neurológiai rendellenességek kezelésére
NO20053302D0 (no) Imidazolderivater med affinitet for alfa 2-reseptoraktivitet.
DE60106168D1 (de) Substituierte 1-aza-2-imino-heterocyclen und ihre verwendung als aktivatoren der nikotinergen acetylcholinrezeptoren
AR034313A1 (es) Utilizacion de derivados de piridoindolona para la preparacion de medicamentos
HUP0204168A2 (hu) Butin-diol-származékok, ilyeneket tartalmazó gyógyszerkészítmény és előállítása